DR. Julie Refuerzo Aspiras, M.D. is a specialist in Oceanside, CA. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Julie Refuerzo Aspiras, M.D. NPI is 1952468183. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
3998 VISTA WAY STE F
OCEANSIDE, CA
ZIP 92056-514
Phone: (760) 630-4678
Fax: (760) 724-1614
The NPI 1952468183 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The CLIA number assigned to this NPI record is 05D0991813 - physician office with a certificate type of Certificate of Waiver.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Destruction of 2-14 skin growths (HCPCS:17003)
- Urinalysis, manual test (HCPCS:81002)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Routine EKG using at least 12 leads including interpretation and report (HCPCS:93000)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Destruction of skin growth (HCPCS:17000)
- Administration of pneumococcal vaccine (HCPCS:G0009)
The enumeration date for this NPI number is 1/3/2007 and was last updated on 2/20/2015.